Keyphrases
Alzheimer's Disease
5%
Antidepressants
10%
Autophagy
16%
Behavioral Effects
9%
Bipolar Disorder
38%
Bipolar Patients
24%
Brain Regions
6%
Calbindin
5%
Calbindin-D28k
7%
Carbamazepine
7%
Cerebrospinal Fluid
5%
Control Subjects
7%
Covalently Bound
5%
Depressive-like Behavior
7%
Fibrinogen
8%
Forced Swim Test
9%
Frontal Cortex
28%
Glycogen Synthase Kinase 3 (GSK3)
39%
Hippocampus
8%
Human Platelets
13%
Hypothalamus
5%
Inositol
75%
Inositol Monophosphatase
30%
Knock-in Mouse Model
12%
Lithium
100%
Lithium Treatment
20%
Lymphocytes
16%
Mechanism of Action
9%
Mitochondria
5%
Mitochondrial Dysfunction
8%
Mitochondrial Function
6%
Mood Stabilizers
12%
MRNA Level
12%
Myo-inositol
10%
Phosphatase
8%
Phosphate
8%
Phosphatidylinositol Synthase
10%
Pilocarpine
7%
Platelet Aggregation
7%
Platelets
21%
Postmortem Brain
20%
Protein Level
25%
Protein Synthesis
6%
Rat Brain
8%
Rotenone
6%
Schizophrenia
33%
Schizophrenic Patients
35%
Stabilizing Effect
5%
Type 2 Diabetes Mellitus (T2DM)
7%
Valproate
14%
Neuroscience
Alzheimer's Disease
7%
Antidepressant
9%
Autophagy
19%
Behavior (Neuroscience)
25%
Behavioral Effect
6%
Bipolar Disorder
39%
Carbamazepine
5%
Dementia Praecox
42%
Diabetes Mellitus
5%
DNA Methylation
6%
Frontal Lobe
30%
Gene Expression
6%
Glycogen Synthase Kinase 3
35%
GSK-3
6%
Hippocampus
8%
Homocysteine
6%
Inositol
68%
Lymphocyte
12%
Metabolic Pathway
7%
Mitochondrial Function
7%
Mood Disorder
7%
Mood Stabilizer
14%
Neuroprotective Agent
8%
Pilocarpine
6%
Reactive Oxygen Species
5%
Rotenone
6%